Abstract
It has been known for almost three decades that steroid aporeceptors exist in a large complex sedimenting at 9S which becomes reduced to about 4S upon ligand binding. Ever-improving tools have helped to provide overwhelming evidence that steroid receptors form hormone-reversible complexes with the heat-shock protein 90 (Hsp90) plus several Hsp90 accessory proteins (Pratt 1993, Smith and Toft 1993, Pratt and Toft 1997, Toft 1997). The protein components of the aporeceptor complex have been characterized and cloned. Assembly can now be recapitulated in vitro with purified components. The vast majority of the evidence that this heterocomplex exists and is relevant to the regulation of steroid receptor activity in cells is based on biochemical experiments in cell-free systems. In the last few years, a variety of experiments including genetic experiments, both in mammalian tissue culture cells and in budding yeast, have begun to fill in this gap. In this review, I will focus on the progress that has been achieved with in vivo experiments.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Blagosklonny MV, Toretsky J, Bohen S, and Neckers L (1996): Mutant conformation of p53 translated in vitro or in vivo requires functional HSP90. Proc. Natl. Acad. Sci. USA 93: 8379–8383.
Blagosklonny MV, Toretsky J, and Neckers L (1995): Geldanamycin selectively destabilizes and conformationally alters mutated p53. Oncogene 11: 933–939.
Bohen SP (1995): Hsp90 mutants disrupt glucocorticoid receptor ligand binding and destabilize aporeceptor complexes. J. Biol. Chem. 270: 29433–29438.
Bohen SP, Kralli A, and Yamamoto KR (1995): Hold’em and fold’em: chaperones and signal transduction. Science 268: 1303–1304.
Bohen SP, and Yamamoto KR (1993): Isolation of Hsp90 mutants by screening for decreased steroid receptor function. Proc. Natl. Acad. Sci. USA 90: 11424–11428.
Borkovich KA, Farrelly FW, Finkelstein DB, Taulien J, and Lindquist S (1989): Hsp82 is an essential protein that is required in higher concentrations for growth of cells at higher temperatures. Mol. Cell. Biol. 9: 3919–3930.
Bresnick EH, Dalman FC, Sanchez ER, and Pratt WB (1989): Evidence that the 90kDa heat shock protein is necessary for the steroid binding conformation of the L cell glucocorticoid receptor. J. Biol. Chem. 264: 4992–4997.
Bunone G, Briand P-A, Miksicek RJ, and Picard D (1996): Activation of the unliganded estrogen receptor by EGF involves the MAP kinase pathway and direct phosphorylation. EMBO J. 15: 2174–2183.
Caplan AJ, Langley E, Wilson EM, and Vidal J (1995): Hormone-dependent transactivation by the human androgen receptor is regulated by a dnaJ protein. J. Biol. Chem. 270: 5251–5257.
Chandran UR, and DeFranco DB (1992): Internuclear migration of chicken progesterone receptor, but not simian virus-40 large tumor antigen, in transient heterokaryons. Mol. Endocrinol. 6: 837–844.
Chang H-CJ, Nathan DF, and Lindquist S (1997): In vivo analysis of the Hsp90 cochaperone Sti1 (p60). Mol. Cell Biol. 17: 318–325.
Chen M-S, Silverstein AM, Pratt WB, and Chinkers M (1996a): The tetratricopeptide repeat domain of protein phosphatase 5 mediates binding to glucocorticoid receptor heterocomplexes and acts as a dominant negative mutant. J. Biol. Chem. 271: 32315–32320.
Chen S, Prapapanich V, Rimerman RA, Honoré B, and Smith DF (1996b): Interactions of p60, a mediator of progesterone receptor assembly, with heat shock proteins Hsp90 and Hsp70. Mol. Endocrinol. 10: 682–693.
Craig EA, Gambill BD, and Nelson RJ (1993): Heat shock proteins: molecular chaperones of protein biogenesis. Microbiol. Rev. 57: 402–414.
Dauvois S, White R, and Parker MG (1993): The antiestrogen ICI182780 disrupts estrogen receptor nucleocytoplasmic shuttling. J. Cell Sci. 106: 1377–1388.
Dittmar KD, Hutchison KA, Owens-Grillo JK, and Pratt W B (1996): Reconstitution of the steroid receptor • hsp90 heterocomplex assembly system of rabbit reticulocyte lysate. J. Biol. Chem. 271: 12833–12839.
Dittmar KD and Pratt WB (1997): Folding of the glucocorticoid receptor by the reconstituted hsp90-based chaperone machinery. J. Biol. Chem. 272: 13047–13054.
Duina AA, Chang H-CJ, Marsh JA, Lindquist S, and Gaber R F (1996a): A cyclophilin function in Hsp90-dependent signal transduction. Science 274: 1713–1715.
Duina AA, Marsh JA, and Gaber RF (1996b): Identification of two CyP-40-like cyclophilins in Saccharomyces cerevisiae, one of which is required for normal growth. Yeast 12: 943–952.
Fang Y, Hiss AE, Robins DM, and Caplan AJ (1996): Hsp90 regulates androgen receptor hormone binding affinity in vivo. J. Biol. Chem. 271: 28697–28702.
Garabedian M J (1993): Genetic approaches to mammalian nuclear receptor function in yeast. Companion Methods Enzymol. 5: 138–146.
Guiochon-Mantel A, Lescop P, Christin-Maitre S, Loosfelt H, Perrot-Applanat M and Milgrom E (1991): Nucleocytoplasmic shuttling of the progesterone receptor. EMBO J. 10: 3851–3859.
Holley SJ, and Yamamoto KR (1995): A role for Hsp90 in retinoid receptor signal transduction. Mol. Biol. Cell 6: 1833–1842.
Hu J, and Seeger C (1996): Hsp90 is required for the activity of a hepatitis B virus reverse transcriptase. Proc. Natl. Acad. Sci. USA 93: 1060–1064.
Hu J, Toft DO, and Seeger C (1997): Hepadnavirus assembly and reverse transcription require a multi-component chaperone complex which is incorporated into nucleocapsids. EMBO J. 16: 59–68.
Hutchison KA, Scherrer LC, Czar MJ, Ning Y, Sanchez ER, Leach KL, Deibel MRJ, and Pratt WB (1993): FK506 binding to the 56-kilodalton inununophilin (Hsp56) in the glucocorticoid receptor heterocomplex has no effect on receptor folding or function. Biochem. 32: 3953–3957.
Johnson J, Corbisier R, Stensgard B, and Toft DO (1996): The involvement of p23, hsp90, and immunophilins in the assembly of progesterone receptor complexes. J. Steroid Biochem. Molec. Biol. 56: 31–37.
Johnson J L and Toft D 0 (1995): Binding of p23 and hsp90 during assembly with the progesterone receptor. Mol. Endocrinol. 9: 670–678.
Kang KI, Devin J, Cadepond F, Jibard N, Guiochon-Mantel A, Baulieu EE, and Catelli MG (1994): In vivo functional protein-protein interaction: nuclear targeted hsp90 shifts cytoplasmic steroid receptor mutants into the nucleus. Proc. Natl. Acad. Sci. USA 91: 340–344.
Kimura Y, Yahara I, and Lindquist S (1995): Role of the protein chaperone YDJ1 in establishing Hsp90-mediated signal transduction pathways. Science 268: 1362–1365.
Kralli A, Bohen SP, and Yamamoto KR (1995): LEM1, an ATP-binding-cassette transporter, selectively modulates the biological potency of steroid hormones. Proc. Natl. Acad. Sci. USA 92: 4701–4705.
Kralli A, and Yamamoto KR (1996): An FK506-sensitive transporter selectively decreases intracellular levels and potency of steroid hormones. J. Biol. Chem. 271: 17152–17156.
Louvion J-F, Warth R, and Picard D (1996): Two eukaryote-specific regions of Hsp82 are dispensable for its viability and signal transduction functions in yeast. Proc. Natl. Acad. Sci. USA 93: 13937–13942.
Mattioni T, Louvion J-F, and Picard D (1994): Regulation of protein activities by fusion to steroid binding domains. In: Protein expression in animal cells, Methods in Cell Biology, Roth M, ed., Vol. 43. Academic Press, pp. 335–352.
Meng X, Devin J, Sullivan WP, Toft D, Baulieu E-E, and Catelli M-G (1996): Mutational analysis of Hsp90a dimerization and subcellular localization: dimer disruption does not impede “in vivo” interaction with estrogen receptor. J. Cell Sci. 109: 1677–1687.
Metzger D, White JH, and Chambon P (1988): The human estrogen receptor functions in yeast. Nature 334: 31–36.
Milad M, Sullivan W, Diehl E, Altmann M, Nordeen S, Edwards DP, and Toft DO (1995): Interaction of the progesterone receptor with binding proteins for FK506 and cyclosporin A. Mol. Endocrinol. 9: 838–847.
Nair SC, Toran EJ, Rimerman RA, Hjermstad S, Smithgall TE, and Smith DF (1996): A pathway of multi-chaperone interactions common to diverse regulatory proteins: Estrogen receptor, Fes tyrosine kinase, heat shock transcription factor HSF1, and the arylhydrocarbon receptor. Cell Stress Chap. 1: 237–250.
Nathan DF, and Lindquist S (1995): Mutational analysis of Hsp90 function: interactions with a steroid receptor and a protein kinase. Mol. Cell. Biol. 15: 3917–3925.
Nicolet CM, and Craig EA (1989): Isolation and characterization of STI1, a stress-inducible gene from Saccharomyces cerevisiae. Mol. Cell Biol. 9: 3638–3646.
Ning Y-M, and Sanchez ER (1996): In vivo evidence for the generation of a glucocorticoid receptor-heat shock protein-90 complex incapable of binding hormone by the calmodulin antagonist phenoxybenzamine. Mol. Endocrinol. 10: 14–23.
Ning YM, and Sanchez ER (1993): Potentiation of glucocorticoid receptor-mediated gene expression by the immunophilin ligands FK506 and rapamycin. J. Biol. Chem. 268: 6073–6076.
O’Malley BW, Schrader WT, Mani S, Smith C, Weigel NL, Conneely OM, and Clark JH (1995): An alternative ligand-independent pathway for activation of steroid receptors. Recent Prog. Harm. Res. 50: 333–347.
Owens-Grillo JK, Czar MJ, Hutchison KA, Hoffman K, Perdew GH, and Pratt WB (1996): A model of protein targeting mediated by immunophilins and other proteins that bind to hsp90 via tetratricopeptide repeat domains J. Biol. Chem. 271: 13468–13475.
Owens-Grillo JK, Hoffmann K, Hutchison KA, Yem AW, Deibel MR, Handschumacher RE, and Pratt WB (1995): The cyclosporin A-binding immunophilin CyP-40 and the FK506-binding immunophilin Hsp56 bind to a common site on Hsp90 and exist in independent cytosolic heterocomplexes with the untransformed glucocorticoid receptor. J. Biol. Chem. 270: 20479–20484.
Pekki A, Ylikomi T, Syvala H, and Tuohimaa P (1994): Progesterone receptor and hsp90 are not complexed in intact nuclei. J. Steroid Biochem. Mol. Biol. 48: 475–479.
Pekki A, Ylikomi T, Syvala H, and Tuohimaa P (1995): Progesterone receptor does not form oligomeric (8S), non-DNA-binding complex in intact cell nuclei. J. Cell Biochem. 58: 95–104.
Picard D (1993): Steroid-binding domains for regulating the functions of heterologous proteins in cis. Trends Cell Biol. 3: 278–280.
Picard D (1994): Regulation of protein function through expression of chimaeric proteins. Curr. Opin. Biotech. 5: 511–515.
Picard D, Bunone G, Liu JW, and Donzé O (1997): Steroid-independent activation of steroid receptors in mammalian and yeast cells and in breast cancer. Biochem. Soc. Trans. 25: 597–602.
Picard D, Khursheed B, Garabedian MJ, Fortin MG, Lindquist S, and Yamamoto KR (1990a): Reduced levels of hsp90 compromise steroid receptor action in vivo. Nature 348: 166–168.
Picard D, Salser SJ, and Yamamoto KR (1988): A movable and regulable inactivation function within the steroid binding domain of the glucocorticoid receptor. Cell 54: 1073–1080.
Picard D, Schena M, and Yamamoto KR (1990b): An inducible expression vector for both fission and budding yeasts. Gene 86: 257–261.
Prapapanich V, Chen S, Nair SC, Rimerman RA, and Smith DF (1996): Molecular cloning of human p48, a transient component of progesterone receptor complexes and an hsp70-binding protein. Mol. Endocrinol. 10: 420–431.
Pratt WB (1993): The role of heat shock proteins in regulating the function, folding, and trafficking of the glucocorticoid receptor. J. Biol. Chem. 268: 21455–21458.
Pratt WB, and Toft DO (1997): Steroid receptor interactions with heat shock protein and immunophilin chaperones. Endocr. Rev. 18: 306–360.
Rafestin-Oblin M-E, Couette B, Radanyi C, Lombes M, and Baulieu E-E (1989): Mineralocorticosteroid receptor of the chick intestine. J. Biol. Chem. 264: 9304–9309.
Ratajczak T, Mark PJ, Martin RL, and Minchin RF (1996): Cyclosporin A potentiates estradiol-induced expression of the cathepsin D gene in MCF7 breast cancer cells. Biochem. Biophys. Res. Commun. 220: 208–212.
Renoir J-M, Bihan SL, Mercier-Bodard C, Gold A, Arjomandi M, Radanyi C, and Baulieu E-E (1994): Effects of immuno suppressants FK506 and rapamycin on the heterooligomeric form of the progesterone receptor. J. Steroid Biochem. Molec. Biol. 48: 101–110.
Renoir JM, Mercier Bodard C, Hoffmann K, Le Bihan S, Ning YM, Sanchez ER, Handschumacher RE, and Baulieu EE (1995): Cyclosporin A potentiates the dexamethasone-induced mouse mammary tumor virus-chloramphenicol acetyltransferase activity in LMCAT cells: a possible role for different heat shock protein-binding immunophilins in glucocorticosteroid receptor-mediated gene expression. Proc. Natl. Acad. Sci. USA 92: 4977–4981.
Rexin M, Busch W, Segnitz B, and Gehring U (1992): Structure of the glucocorticoid receptor in intact cells in the absence of hormone. J. Biol. Chem. 267: 9619–9621.
Sakai D, and Gorski J (1984): Reversible denaturation of the estrogen receptor and estimation of polypeptide chain molecular weight. Endocrinology 115: 2379–2383.
Schulte TW, Blagosklonny MV, Ingui C, and Neckers L (1995): Disruption of the Raf1-Hsp90 molecular complex results in destabilization of Raf-1 and loss of Raf-l-Ras association. J. Biol. Chem. 270: 24585–24588.
Schulte TW, Blagosklonny MV, Romanova L, Mushinski JF, Monia BP, Johnston JF, Nguyen P, Trepel J, and Neckers LM (1996): Destabilization of Raf-1 by geldanamycin leads to disruption of the Raf-1-MEK-mitogen-activated protein kinase signalling pathway. Mol. Cell. Biol. 16: 5839–5845.
Segnitz B, and Gehring U (1995): Subunit structure of the nonactivated human estrogen receptor. Proc. Natl. Acad. Sci. USA 92: 2179–2183.
Smith DF (1993): Dynamics of heat shock protein 90-progesterone receptor binding and the disactivation loop model for steroid receptor complexes. Mol. Endocrinol. 7: 1418–1429.
Smith DF, and Toft DO (1993): Steroid receptors and their associated proteins. Mol. Endocrinol. 7: 4–11.
Smith DF, Whitesell L, Nair SC, Chen S, Prapapanich V, and Rimerman RA (1995): Progesterone receptor structure and function altered by geldanamycin, an hsp90binding agent. Mol. Cell. Biol. 15: 6804–6812.
Sullivan WP, and Toft DO (1993): Mutational analysis of hsp90 binding to the progesterone receptor. J. Biol. Chem. 268: 20373–20379.
Tai PK, Albers MW, McDonnell DP, Chang H, Schreiber SL, and Faber LE (1994): Potentiation of progesterone receptor-mediated transcription by the immunosuppressant FK506. Biochem. 33: 10666–10671.
Toft DO (1997): Protein activity control: hormone receptor function. In: Molecular biology of chaperones and folding catalysts, Bukau B, ed. Harwood Academic Publications.
Tuohimaa P, Pekki A, Blauer M, Joensuu T, Vilja P, and Ylikomi T (1993): Nuclear progesterone receptor is mainly heat shock protein 90-free in vivo. Proc. Natl Acad. Sci. USA 90: 5848–5852.
Warth R, Briand P-A, and Picard D (1997): Functional analysis of the yeast 40 kDa cyclophilin Cyp40 and its role for viability and steroid receptor regulation. Biol. Chem. 378: 381–391.
Whitesell L, and Cook P (1996): Stable and specific binding of heat shock protein 90 by geldanamycin disrupts glucocorticoid receptor function in intact cells. Mol. Endocrinol. 10: 705–712.
Whitesell L, Mimnaugh E G, De Costa B, Myers C E and Neckers L M (1994): Inhibition of heat shock protein HSP90-pp60v-src heteroprotein complex formation by benzoquinone ansamycins: essential role for stress proteins in oncogenic transformation. Proc. Natl. Acad. Sci. USA 91: 8324–8328.
Yamamoto KR, Godowski PJ, and Picard D (1988): Ligand regulated nonspecific inactivation of receptor function: A versatile mechanism for signal transduction. Cold Spring Harbor Symp. Quant. Biol. 53: 803–811.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer Science+Business Media New York
About this chapter
Cite this chapter
Picard, D. (1998). The Role of Heat-Shock Proteins in the Regulation of Steroid Receptor Function. In: Freedman, L.P. (eds) Molecular Biology of Steroid and Nuclear Hormone Receptors. Progress in Gene Expression. Birkhäuser, Boston, MA. https://doi.org/10.1007/978-1-4612-1764-0_1
Download citation
DOI: https://doi.org/10.1007/978-1-4612-1764-0_1
Publisher Name: Birkhäuser, Boston, MA
Print ISBN: 978-1-4612-7271-7
Online ISBN: 978-1-4612-1764-0
eBook Packages: Springer Book Archive